Expression of foxp3 tumour infiltrating lymphocytes in her2 positive breast cancer and their association with clinicopathological features

Background: The transcription factor Forkhead Box Protein P3 (FOXP3) plays a crucial role in regulatory T cells (Tregs) development and function and serves as a lineage specification factor of Tregs. FOXP3+ tumour infiltrating lymphocytes (TILs) are considered significant prognostic markers in breas...

Full description

Bibliographic Details
Main Author: Hashim, Sobry
Format: Thesis
Language:English
Published: 2023
Subjects:
Online Access:http://eprints.usm.my/62767/
http://eprints.usm.my/62767/1/Sobry%20Hashim%20-%20E.pdf
_version_ 1848885083287584768
author Hashim, Sobry
author_facet Hashim, Sobry
author_sort Hashim, Sobry
building USM Institutional Repository
collection Online Access
description Background: The transcription factor Forkhead Box Protein P3 (FOXP3) plays a crucial role in regulatory T cells (Tregs) development and function and serves as a lineage specification factor of Tregs. FOXP3+ tumour infiltrating lymphocytes (TILs) are considered significant prognostic markers in breast cancer. However, the prognostic significance of FOXP3+ TILs in human epidermal growth factor receptor 2 (HER2) positive breast cancers remains controversial. We investigated the proportion of HER2-positive breast cancer and their expression of FOXP3+ TILs and evaluated their association with clinicopathological features. Methods: A cross-sectional study was conducted involving 167 formalin-fixed paraffin-embedded (FFPE) tissue samples of HER2-positive breast cancer cases from the Department of Pathology, Hospital Sultanah Nur Zahirah (HSNZ) from the year of 2014 to 2021. The tissue sections were stained with immunohistochemistry (IHC) anti-FoxP3 antibodies. FOXP3+ TILs expression was categorised into low infiltration (grade 0 to grade 1) and high infiltration (grade 2 to grade 3). Fischer’s Exact test was used to analyse the association with clinicopathological characteristics. A p-value of less than 0.05 was considered statistically significant. Results: Total breast cancer cases from 2014-2021 were 1066 cases. There were 272 (25.5%) HER2-positive breast cancer cases. Among 167 selected HER2-positive breast cancer cases, 164 (98.2%) cases showed strong FOXP3+ TILs infiltration, and 3 (1.8%) cases showed low infiltration. There was no significant association between the expression of FOXP3+ TILs with the age of diagnosed (p > 0.950), tumour grade (p=0.091), tumour size (p=0.235), axillary nodal status (p=0.552), metastasis status (p > 0.950), oestrogen receptor (ER) status (p=0.616) and progesterone receptor (PR) status (p > 0.950). Conclusion: FOXP3+ TILs were highly infiltrating HER2-positive breast cancer despite variability in clinicopathological characteristics.
first_indexed 2025-11-15T19:16:57Z
format Thesis
id usm-62767
institution Universiti Sains Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T19:16:57Z
publishDate 2023
recordtype eprints
repository_type Digital Repository
spelling usm-627672025-08-18T08:39:11Z http://eprints.usm.my/62767/ Expression of foxp3 tumour infiltrating lymphocytes in her2 positive breast cancer and their association with clinicopathological features Hashim, Sobry R Medicine RC254-282 Neoplasms. Tumors. Oncology (including Cancer) Background: The transcription factor Forkhead Box Protein P3 (FOXP3) plays a crucial role in regulatory T cells (Tregs) development and function and serves as a lineage specification factor of Tregs. FOXP3+ tumour infiltrating lymphocytes (TILs) are considered significant prognostic markers in breast cancer. However, the prognostic significance of FOXP3+ TILs in human epidermal growth factor receptor 2 (HER2) positive breast cancers remains controversial. We investigated the proportion of HER2-positive breast cancer and their expression of FOXP3+ TILs and evaluated their association with clinicopathological features. Methods: A cross-sectional study was conducted involving 167 formalin-fixed paraffin-embedded (FFPE) tissue samples of HER2-positive breast cancer cases from the Department of Pathology, Hospital Sultanah Nur Zahirah (HSNZ) from the year of 2014 to 2021. The tissue sections were stained with immunohistochemistry (IHC) anti-FoxP3 antibodies. FOXP3+ TILs expression was categorised into low infiltration (grade 0 to grade 1) and high infiltration (grade 2 to grade 3). Fischer’s Exact test was used to analyse the association with clinicopathological characteristics. A p-value of less than 0.05 was considered statistically significant. Results: Total breast cancer cases from 2014-2021 were 1066 cases. There were 272 (25.5%) HER2-positive breast cancer cases. Among 167 selected HER2-positive breast cancer cases, 164 (98.2%) cases showed strong FOXP3+ TILs infiltration, and 3 (1.8%) cases showed low infiltration. There was no significant association between the expression of FOXP3+ TILs with the age of diagnosed (p > 0.950), tumour grade (p=0.091), tumour size (p=0.235), axillary nodal status (p=0.552), metastasis status (p > 0.950), oestrogen receptor (ER) status (p=0.616) and progesterone receptor (PR) status (p > 0.950). Conclusion: FOXP3+ TILs were highly infiltrating HER2-positive breast cancer despite variability in clinicopathological characteristics. 2023 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/62767/1/Sobry%20Hashim%20-%20E.pdf Hashim, Sobry (2023) Expression of foxp3 tumour infiltrating lymphocytes in her2 positive breast cancer and their association with clinicopathological features. Masters thesis, Universiti Sains Malaysia.
spellingShingle R Medicine
RC254-282 Neoplasms. Tumors. Oncology (including Cancer)
Hashim, Sobry
Expression of foxp3 tumour infiltrating lymphocytes in her2 positive breast cancer and their association with clinicopathological features
title Expression of foxp3 tumour infiltrating lymphocytes in her2 positive breast cancer and their association with clinicopathological features
title_full Expression of foxp3 tumour infiltrating lymphocytes in her2 positive breast cancer and their association with clinicopathological features
title_fullStr Expression of foxp3 tumour infiltrating lymphocytes in her2 positive breast cancer and their association with clinicopathological features
title_full_unstemmed Expression of foxp3 tumour infiltrating lymphocytes in her2 positive breast cancer and their association with clinicopathological features
title_short Expression of foxp3 tumour infiltrating lymphocytes in her2 positive breast cancer and their association with clinicopathological features
title_sort expression of foxp3 tumour infiltrating lymphocytes in her2 positive breast cancer and their association with clinicopathological features
topic R Medicine
RC254-282 Neoplasms. Tumors. Oncology (including Cancer)
url http://eprints.usm.my/62767/
http://eprints.usm.my/62767/1/Sobry%20Hashim%20-%20E.pdf